Prospective epidemiological study of the prevalence of human leukocyte antigen (HLA)-B5701 in HIV-1-infected UK subjects

HIV Medicine

Volumn 11, Issue 3, 2010, Pages 187-192

  Orkin, C ^a   Sadiq, S T ^b   Rice, L ^c   Jackson, F ^c  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Abacavir; African; HLA B*5701; Prevalence; UK

Indexed keywords

ABACAVIR; HLA ANTIGEN; HLA B5701 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CAUCASIAN; CHEEK; CONTROLLED STUDY; DRUG EXPOSURE; EPIDEMIOLOGICAL DATA; ETHNIC DIFFERENCE; FEMALE; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NEGRO; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; UNITED KINGDOM;

ADULT; AFRICA; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ANTI-HIV AGENTS; DIDEOXYNUCLEOSIDES; DRUG HYPERSENSITIVITY; EPIDEMIOLOGIC STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC MARKERS; GENETIC TESTING; GENOTYPE; GREAT BRITAIN; HIV INFECTIONS; HLA-B ANTIGENS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 75749085418     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2009.00762.x     Document Type: Article

References (15)

1. Mallal S, Phillips E, Carosi G. PREDICT-1: a novel randomized prospective study to determine the clinical utility of HLA-B*5701 screening to reduce abacavir hypersensitivity in HIV-1 infected subjects (study CNA106030). N Engl J Med 2008, 358:568-579.
2. Saag M, Balu R, Brachman P. High sensitivity of HLA-B*5701 in Whites and Blacks in immunologically confirmed cases of hypersensitivity (ABC HSR). Clin Infect Dis 2008, 46:1111-1118.
3. Campbell MC, Tishkoff SA. African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping. Ann Rev Genom Hum Genet 2008, 9:403-433.
4. Sadiq ST, Pakianathan M. Uncertainties of routine HLA B*5701 testing in black African HIV cohorts in the UK. Sex Transm Inf 2007, 83:173.
5. Reeves I, Churchill D, Fisher M. Screening for HLA-B*5701 reduces the frequency of abacavir hypersensitivity reactions. Antivir Ther 2006, 11:L11.
6. Ramachandran S, Rosenberg NA, Zhivotovsky LA, Feldman MW. Robustness of the inference of human population structure: a comparison of X-chromosomal and autosomal microsatellites. Hum Genom 2004, 1:87-97.
7. Basto-Rodrigues L, Pimenta JR, Pena SDJ. The genetic structure of human populations studied through short insertion-deletion polymorphisms. Ann Hum Genet 2006, 70:658-665.
8. Lewis MP. Ethnologue: Languages of the World 2009, http://www.ethnologue.com/family_index.asp, ed., 16th edn, Dallas, TX, SIL International, Available at, (accessed 28 April 2009)
9. Cavalli-Sforza LL, Feldman MC. The application of molecular genetic approaches to the study of human evolution. Nat Genet 2003, 33((Suppl.)):266-275.
10. SOPHID Regional Data 2003, Health Protection Agency., London, Health Protection Agency
11. Wilson EB. Probable inference, the law of succession, and statistical inference. J Am Statist Assoc 1927, 22:209-212.
12. Daly AK, Donaldson PT, Bhatnagar P. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet 2009, 41:816-819.
13. Waters LJ, Mandalia S, Gazzard B, Nelson M. Prospective HLA-BM5701 screening and abacavir hypersensitivity: a single centre experience. AIDS 2007, 21:2533-2549.
14. Nettle D, Harris L. Genetic and linguistic affinities between human populations in Eurasia and West Africa. Hum Biol 2003, 75:331-344.
15. Tishkoff SA, Reed FA, Friedlaender FR. The genetic structure and history of Africans and African Americans. Science 2009, 324:1035-1044.